Yu Wenjing, Shi Xiaowei, Cui Xia, Niu Yan, Zhang Wen, Bai Xue, Wang Qian, Hu Lijun, Wang Sumei
Department of Pediatrics, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
Neuropsychiatr Dis Treat. 2018 Dec 17;14:3381-3392. doi: 10.2147/NDT.S185169. eCollection 2018.
This study explored whether Jian-Pi-Zhi-Dong-Decoction (JPZDD) could regulate the metabolism of glutamate (GLU) and its transporters in the striatum to exert anti-tics effects in Tourette syndrome (TS) rats.
We randomly assigned 56 Sprague Dawley rats into four groups, each with 14 rats: control, model, tiapride (Tia), and JPZDD. TS groups (model, Tia, and JPZDD) received intraperitoneal injection of 3,3'-iminodipropionitrile for 7 days to establish TS model. Thereafter, rats in the four groups were treated differently once a day for 6 weeks. Behavioral evaluation was performed each week by using stereotypy recording and autonomic activity test. The level of GLU in the striatum was examined by high-performance liquid chromatography. Expression of EAAT1 and VGLUT1 were measured by quantitative real-time PCR (qRT-PCR) and laser scanning confocal microscope.
Compared with the model group, the stereotypy score and autonomic activity were decreased in Tia and JPZDD groups. Notably, the model group had increased concentration of GLU, which decreased after JPZDD and Tia treatments. In the model group, EAAT1 and glial cells were highly co-expressed and the relative fluorescence intensity (FI) of EAAT1 was significantly lower than that in the control group. Treatment with JPZDD and Tia increased the relative FI of EAAT1. The mRNA level of EAAT1 decreased in the model group compared to that in the control group, although it was significantly elevated following JPZDD or Tia treatment. In the model group, there was low co-expression of VGLUT1 and axon cells and the FI of VGLUT1 was remarkably increased relative to that in the control group and reduced following treatment with JPZDD and Tia. A similar trend was observed in the mRNA and protein expression of VGLUT1, although it was not statistically significant.
The mechanism by which JPZDD alleviated behavioral dysfunction of TS rats may be associated with maintaining normal GLU transport by upregulating EAAT1 and down-regulating VGLUT1 in the striatum.
本研究探讨健脾止动汤(JPZDD)是否可通过调节纹状体中谷氨酸(GLU)及其转运体的代谢,从而对抽动秽语综合征(TS)大鼠发挥抗抽动作用。
将56只Sprague Dawley大鼠随机分为四组,每组14只:对照组、模型组、硫必利(Tia)组和JPZDD组。TS组(模型组、Tia组和JPZDD组)腹腔注射3,3'-亚氨基二丙腈7天以建立TS模型。此后,四组大鼠每天接受不同处理,持续6周。每周通过刻板行为记录和自主活动测试进行行为评估。采用高效液相色谱法检测纹状体中GLU的水平。通过定量实时聚合酶链反应(qRT-PCR)和激光扫描共聚焦显微镜检测兴奋性氨基酸转运体1(EAAT1)和囊泡谷氨酸转运体1(VGLUT1)的表达。
与模型组相比,Tia组和JPZDD组的刻板行为评分和自主活动减少。值得注意的是,模型组GLU浓度升高,经JPZDD和Tia治疗后降低。在模型组中,EAAT1与神经胶质细胞高度共表达,且EAAT1的相对荧光强度(FI)显著低于对照组。JPZDD和Tia治疗可增加EAAT1的相对FI。与对照组相比,模型组EAAT1的mRNA水平降低,尽管经JPZDD或Tia治疗后显著升高。在模型组中,VGLUT1与轴突细胞共表达较低,且VGLUT1的FI相对于对照组显著增加,经JPZDD和Tia治疗后降低。VGLUT1的mRNA和蛋白表达也观察到类似趋势,尽管无统计学意义。
JPZDD减轻TS大鼠行为功能障碍的机制可能与上调纹状体中EAAT1和下调VGLUT1以维持正常GLU转运有关。